Formulation and Evaluation of Delayed Release Enteric Coated Tablets of Tenatoprazole, by Optimizing the Plymers

  • سال انتشار: 1399
  • محل انتشار: فصلنامه تحقیقات جاری در داروسازی، دوره: 6، شماره: 1
  • کد COI اختصاصی: JR_TIPS-6-1_003
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 301
دانلود فایل این مقاله

نویسندگان

Nikunja B Pati

Dept. of Pharmaceutics, Faculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University (Pulla Reddy Institute of Pharmacy), Hyderabad, India.

Swapna Velivela

Dept. of Pharmaceutics, Faculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University (Pulla Reddy Institute of Pharmacy), Hyderabad, India.

Vinyas Mayasa

Dept. of Pharmaceutics, Faculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University (Pulla Reddy Institute of Pharmacy), Hyderabad, India.

Ravindra Babu Baggi

Dept. of Pharmaceutics, Faculty of Pharmaceutical Sciences, Jawaharlal Nehru Technological University (Pulla Reddy Institute of Pharmacy), Hyderabad, India.

چکیده

The present study was undertaken with an aim to formulate enteric coated tablets of Tenatoprazole (a novel proton pump inhibitor with an imidazopyridine ring) to improve bioavailability by avoiding degradation. Different core tablets were prepared using approved excipients by direct compression method and evaluated for different parameters like hardness, thickness, friability and disintegration time. Sub-coating was done for optimized formulation (F5) by using HPMC 5 cps with buildup of 3% w/w and finally enteric coating was done by using HPMCP, Eudragit L30 D55 and HPMC Acetate succinate (HPMCAS) with an average weight buildup of 5%, 8% and 10% w/w. all formulations were evaluated for different parameters like hardness, friability, thickness, disintegration time, drug content and dissolution studies and compared with marketed sample. Results indicated that, methacrylic acid polymers exhibited better dissolution rate than cellulose polymers. The optimized formulation was subjected to stability studies as per ICH guidelines for 3 months and was observed that no significant change was observed.

کلیدواژه ها

Sub-coating, enteric coating tablets, HPMCP, Eudragit L30 D55, HPMCAS, Stability studies

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.